Home / Contract Awards / Amyx Gets $189M JIDO Mission Support Task Order Under GSA OASIS SB Vehicle

Amyx Gets $189M JIDO Mission Support Task Order Under GSA OASIS SB Vehicle

Reston, Virginia-based information technology platforms provider Amyx has secured a potential five-year, $189.2 million task order from the General Services Administration to provide mission support services to the Joint Improvised-Threat Defeat Organization.

GSA’s federal systems integration and management center received eight bids for the cost-plus-award-fee task order that was awarded under the Pool 1 category of the One Acquisition Solution for Integrated Services Small Business contract vehicle,  the Defense Department said Monday.

The order covers system engineering, JIDO operations support, technical assistance, acquisition and program management, logistics, mission-based research, communications and event support, analytical assistance, facilities safety, security assurance and human capital management services.

GSA will obligate $4.2 million in joint IED defeat funds at the time of award, according to DoD.

The contractor will perform work in Virginia and the National Capital Region through Jan. 17, 2022 under the task order, which is part of JIDO’s Enterprise Acquisition Strategy Initiative that seeks to comply with acquisition policies and meet mission requirements.

GSA officially launched the OASIS SB vehicle in June 2014 to serve as a platform for federal agencies to procure professional services.

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.